J Venom Anim Toxins incl Trop Dis

Background: Accidents caused by spiders of the genus Loxosceles constitute an important public health problem in Brazil. The venom of Loxosceles sp induces dermonecrosis at the bite site and systemic disease in severe cases. Traditional medicine based on plant-derived products has been proven to reduce the local effects of envenomation. The present study verified the healing effects of copaiba oil on lesions induced by the venom of L. intermedia. Methods: Cutaneous lesions were induced on the backs of rabbits by intradermal injection of L. intermedia venom. Copaiba oil was applied topically 6 hours after injection; the treatment was repeated for 30 days, after which animal skins were removed and processed for histopathological analysis. Blood samples were also collected before and 24 hours after venom inoculation to measure the hematological parameters. Results: Compared to the control group, the platelet count was reduced significantly in all groups inoculated with venom, accompanied by a decreased number of heterophils in the blood. The minimum necrotic dose (MND) was defined as 2.4 μg/kg. Topical treatment with copaiba oil demonstrated a differentiated healing profile: large skin lesions were observed 10 days after venom inoculation, whereas formation of a thick crust, without scarring was observed 30 days after venom inoculation. Histopathological analysis showed no significant difference after treatment. Nevertheless, the copaiba oil treatment induced a collagen distribution similar to control skin, in marked contrast to the group that received only the spider venom injection. Conclusions: We conclude that copaiba oil may interfere in the healing process and thus propose it as a possible topical treatment for cutaneous lesions induced by L. intermedia venom. * Correspondence: marafernandesribeiro@gmail.com https://dx.doi.org/10.1590/1678–9199–JVATITD–1493–18 Received: 23 August 2018; Accepted: 01 February 2019; Published online: 25 April 2019 J Venom Anim Toxins incl Trop Dis, 2019 25: e149318 RESEARCH OPEN ACESS

[1]  M. Hallek.  Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment , 2019, American journal of hematology.

[2]  S. Feske,et al.  Ion channelopathies of the immune system. , 2018, Current opinion in immunology.

[3]  D. Fadool,et al.  Elevated Anxiety and Impaired Attention in Super-Smeller, Kv1.3 Knockout Mice , 2018, Front. Behav. Neurosci..

[4]  J. Tytgat,et al.  Toxins in Drug Discovery and Pharmacology , 2018, Toxins.

[5]  F. Ribeiro,et al.  Animal Toxins as Therapeutic Tools to Treat Neurodegenerative Diseases , 2018, Front. Pharmacol..

[6]  A. Felipe,et al.  Kv1.3: a multifunctional channel with many pathological implications , 2018, Expert opinion on therapeutic targets.

[7]  V. A. Dorce,et al.  Effects of Brazilian scorpion venoms on the central nervous system , 2018, Journal of Venomous Animals and Toxins including Tropical Diseases.

[8]  R. Norton,et al.  Sea Anemones: Quiet Achievers in the Field of Peptide Toxins , 2018, Toxins.

[9]  K. Chandy,et al.  Venom-derived peptide inhibitors of voltage-gated potassium channels , 2017, Neuropharmacology.

[10]  A. Jemal,et al.  Breast cancer statistics, 2017, racial disparity in mortality by state , 2017, CA: a cancer journal for clinicians.

[11]  T. Galvão,et al.  Prevalência de doença renal crônica em adultos no Brasil: revisão sistemática da literatura , 2017 .

[12]  L. Possani,et al.  Arthropod toxins acting on neuronal potassium channels , 2017, Neuropharmacology.

[13]  R. Norton,et al.  Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog. , 2017, Clinical immunology.

[14]  B. Peng,et al.  Kv1.3 channel blocker (ImKTx88) maintains blood–brain barrier in experimental autoimmune encephalomyelitis , 2017, Cell & Bioscience.

[15]  K. Chandy,et al.  Peptide blockers of Kv1.3 channels in T cells as therapeutics for autoimmune disease. , 2017, Current opinion in chemical biology.

[16]  J. Chen,et al.  Discovery of three toxin peptides with Kv1.3 channel and IL-2 cytokine-inhibiting activities from Non-Buthidae scorpions, Chaerilus tricostatus and Chaerilus tryznai , 2017, Peptides.

[17]  L. D. dos Santos,et al.  Heterologous fibrin sealant derived from snake venom: from bench to bedside – an overview , 2017, Journal of Venomous Animals and Toxins including Tropical Diseases.

[18]  B. Ameredes,et al.  NF‐&kgr;B Mediates Mesenchymal Transition, Remodeling, and Pulmonary Fibrosis in Response to Chronic Inflammation by Viral RNA Patterns , 2017, American journal of respiratory cell and molecular biology.

[19]  A. Oliveira,et al.  Multiple uses of fibrin sealant for nervous system treatment following injury and disease , 2017, Journal of Venomous Animals and Toxins including Tropical Diseases.

[20]  J. DeVoss,et al.  Potassium channels Kv1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions , 2017, Nature Communications.

[21]  Caroline F. B. Mourão,et al.  Antiviral activity of animal venom peptides and related compounds , 2017, Journal of Venomous Animals and Toxins including Tropical Diseases.

[22]  P. Herdewijn,et al.  Structural and Functional Elucidation of Peptide Ts11 Shows Evidence of a Novel Subfamily of Scorpion Venom Toxins , 2016, Toxins.

[23]  Anton O. Chugunov,et al.  Kalium: a database of potassium channel toxins from scorpion venom , 2016, Database J. Biol. Databases Curation.

[24]  Z. Cao,et al.  The Scorpion Toxin Analogue BmKTX-D33H as a Potential Kv1.3 Channel-Selective Immunomodulator for Autoimmune Diseases , 2016, Toxins.

[25]  J. Tytgat,et al.  Immunosuppressive evidence of Tityus serrulatus toxins Ts6 and Ts15: insights of a novel K+ channel pattern in T cells , 2016, Immunology.

[26]  Manuela Berto Pucca,et al.  Tityus serrulatus venom--A lethal cocktail. , 2015, Toxicon : official journal of the International Society on Toxinology.

[27]  E. Grishin,et al.  Diversity of Potassium Channel Ligands: Focus on Scorpion Toxins , 2015, Biochemistry (Moscow).

[28]  L. Faccioli,et al.  Immunomodulatory activity of Tityus serrulatus scorpion venom on human T lymphocytes , 2015, Journal of Venomous Animals and Toxins including Tropical Diseases.

[29]  P. Calabresi,et al.  Antigenic Stimulation of Kv1.3-Deficient Th Cells Gives Rise to a Population of Foxp3-Independent T Cells with Suppressive Properties , 2015, The Journal of Immunology.

[30]  K. Michalak,et al.  Voltage-Gated Potassium Channels Kv1.3--Potentially New Molecular Target in Cancer Diagnostics and Therapy. , 2015, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[31]  B. Peng,et al.  Toxins Targeting the KV1.3 Channel: Potential Immunomodulators for Autoimmune Diseases , 2015, Toxins.

[32]  S. Feske,et al.  Ion channels in innate and adaptive immunity. , 2015, Annual review of immunology.

[33]  V. Quintero-Hernández,et al.  Structure, Molecular Modeling, and Function of the Novel Potassium Channel Blocker Urotoxin Isolated from the Venom of the Australian Scorpion Urodacus yaschenkoi , 2014, Molecular Pharmacology.

[34]  G. Schabbauer,et al.  Immunosuppressive peptides and their therapeutic applications , 2014, Drug discovery today.

[35]  Z. Cao,et al.  Unusual binding mode of scorpion toxin BmKTX onto potassium channels relies on its distribution of acidic residues. , 2014, Biochemical and biophysical research communications.

[36]  R. Norton,et al.  A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases , 2014, Scientific Reports.

[37]  J. Tytgat,et al.  Electrophysiological Characterization of Ts6 and Ts7, K+ Channel Toxins Isolated through an Improved Tityus serrulatus Venom Purification Procedure , 2014, Toxins.

[38]  June-Bum Kim.  Channelopathies , 2014, Korean journal of pediatrics.

[39]  D. Farber,et al.  Human memory T cells: generation, compartmentalization and homeostasis , 2013, Nature Reviews Immunology.

[40]  L. Kaczmarek,et al.  Expression of Kv1.3 potassium channels regulates density of cortical interneurons , 2013, Developmental neurobiology.

[41]  L. Possani,et al.  OcyKTx2, a new K+-channel toxin characterized from the venom of the scorpion Opisthacanthus cayaporum , 2013, Peptides.

[42]  BenNasr Hmed,et al.  Scorpion Peptides: Potential Use for New Drug Development , 2013, Journal of toxicology.

[43]  Nicholas R Casewell,et al.  Complex cocktails: the evolutionary novelty of venoms. , 2013, Trends in ecology & evolution.

[44]  W. Chuang,et al.  Recombinant Expression of Margatoxin and Agitoxin-2 in Pichia pastoris: An Efficient Method for Production of KV1.3 Channel Blockers , 2012, PloS one.

[45]  Y. Rosenstein,et al.  Vm24, a Natural Immunosuppressive Peptide, Potently and Selectively Blocks Kv1.3 Potassium Channels of Human T Cells , 2012, Molecular Pharmacology.

[46]  Steve Peigneur,et al.  Novel potassium channel blocker venom peptides from Mesobuthus gibbosus (Scorpiones: Buthidae). , 2012, Toxicon : official journal of the International Society on Toxinology.

[47]  K. Tucker,et al.  Diet‐Induced Obesity Resistance of Kv1.3−/− Mice is Olfactory Bulb Dependent , 2012, Journal of neuroendocrinology.

[48]  M. Xiang,et al.  Identification of a new specific Kv1.3 channel blocker, Ctri9577, from the scorpion Chaerilus tricostatus , 2012, Peptides.

[49]  P. Calabresi,et al.  Kv1.3 Deletion Biases T Cells toward an Immunoregulatory Phenotype and Renders Mice Resistant to Autoimmune Encephalomyelitis , 2012, The Journal of Immunology.

[50]  R. C. Rodríguez de la Vega,et al.  Structure, function, and chemical synthesis of Vaejovis mexicanus peptide 24: a novel potent blocker of Kv1.3 potassium channels of human T lymphocytes. , 2012, Biochemistry.

[51]  K. Chandy,et al.  Durable Pharmacological Responses from the Peptide ShK-186, a Specific Kv1.3 Channel Inhibitor That Suppresses T Cell Mediators of Autoimmune Disease , 2012, Journal of Pharmacology and Experimental Therapeutics.

[52]  Yingliang Wu,et al.  Structural and Functional Diversity of Acidic Scorpion Potassium Channel Toxins , 2012, PloS one.

[53]  Shunyi Zhu,et al.  Two dyad-free Shaker-type K⁺ channel blockers from scorpion venom. , 2012, Toxicon : official journal of the International Society on Toxinology.

[54]  E. Condom,et al.  Differential Expression of Kv1.3 and Kv1.5 Voltage-Dependent K+ Channels in Human Skeletal Muscle Sarcomas , 2012, Cancer investigation.

[55]  Yingliang Wu,et al.  Hg1, Novel Peptide Inhibitor Specific for Kv1.3 Channels from First Scorpion Kunitz-type Potassium Channel Toxin Family* , 2012, The Journal of Biological Chemistry.

[56]  Shin-Ho Chung,et al.  Modeling the binding of three toxins to the voltage-gated potassium channel (Kv1.3). , 2011, Biophysical journal.

[57]  J. Margolick,et al.  Functional Blockade of the Voltage-gated Potassium Channel Kv1.3 Mediates Reversion of T Effector to Central Memory Lymphocytes through SMAD3/p21cip1 Signaling* , 2011, The Journal of Biological Chemistry.

[58]  S. Qiu,et al.  SdPI, The First Functionally Characterized Kunitz-Type Trypsin Inhibitor from Scorpion Venom , 2011, PloS one.

[59]  H. Wulff,et al.  The lymphocyte potassium channels Kv1.3 and KCa3.1 as targets for immunosuppression , 2011, Drug development research.

[60]  Andrea Becchetti,et al.  Ion channels and transporters in cancer. 1. Ion channels and cell proliferation in cancer. , 2011, American journal of physiology. Cell physiology.

[61]  A. Arcangeli,et al.  American Journal of Physiology-Cell Physiology theme: ion channels and transporters in cancer. , 2011, American journal of physiology. Cell physiology.

[62]  Shunyi Zhu,et al.  Molecular divergence of two orthologous scorpion toxins affecting potassium channels. , 2011, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

[63]  Yingliang Wu,et al.  ImKTx1, a new Kv1.3 channel blocker with a unique primary structure , 2011, Journal of biochemical and molecular toxicology.

[64]  J. Tytgat,et al.  Purification and characterization of Ts15, the first member of a new α-KTX subfamily from the venom of the Brazilian scorpion Tityus serrulatus. , 2011, Toxicon : official journal of the International Society on Toxinology.

[65]  Yingliang Wu,et al.  ImKTx88, a novel selective Kv1.3 channel blocker derived from the scorpion Isometrus maculates. , 2011, Toxicon : official journal of the International Society on Toxinology.

[66]  So Yeong Lee,et al.  Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo. , 2011, European journal of pharmacology.

[67]  Shunyi Zhu,et al.  A potent potassium channel blocker from Mesobuthus eupeus scorpion venom. , 2010, Biochimie.

[68]  Yong Zhao,et al.  Molecular Diversity and Functional Evolution of Scorpion Potassium Channel Toxins* , 2010, Molecular & Cellular Proteomics.

[69]  Annette Lee,et al.  Genome-wide association study in alopecia areata implicates both innate and adaptive immunity , 2010, Nature.

[70]  Heike Wulff,et al.  Voltage-gated potassium channels as therapeutic targets , 2009, Nature Reviews Drug Discovery.

[71]  K. Takimoto,et al.  Localization of Kv1.3 Channels in the Immunological Synapse Modulates the Calcium Response to Antigen Stimulation in T Lymphocytes1 , 2009, The Journal of Immunology.

[72]  L. Possani,et al.  Tst26, a novel peptide blocker of Kv1.2 and Kv1.3 channels from the venom of Tityus stigmurus. , 2009, Toxicon : official journal of the International Society on Toxinology.

[73]  K. Chandy,et al.  The functional network of ion channels in T lymphocytes , 2009, Immunological reviews.

[74]  Yingliang Wu,et al.  Molecular cloning and functional identification of a new K+ channel blocker, LmKTx10, from the scorpion Lychas mucronatus , 2009, Peptides.

[75]  J. Tytgat,et al.  A new Kaliotoxin selective towards Kv1.3 and Kv1.2 but not Kv1.1 channels expressed in oocytes. , 2008, Biochemical and biophysical research communications.

[76]  R. C. Rodríguez de la Vega,et al.  A selective blocker of Kv1.2 and Kv1.3 potassium channels from the venom of the scorpion Centruroides suffusus suffusus. , 2008, Biochemical pharmacology.

[77]  D. Shahbazzadeh,et al.  Hemitoxin, the first potassium channel toxin from the venom of the Iranian scorpion Hemiscorpius lepturus , 2008, The FEBS journal.

[78]  Li Wenxin,et al.  Characterization of a new Kv1.3 channel-specific blocker, J123, from the scorpion Buthus martensii Karsch , 2008, Peptides.

[79]  Hui Liu,et al.  Structural Basis of a Potent Peptide Inhibitor Designed for Kv1.3 Channel, a Therapeutic Target of Autoimmune Disease* , 2008, Journal of Biological Chemistry.

[80]  J. Tytgat,et al.  OdK2, a Kv1.3 channel-selective toxin from the venom of the Iranian scorpion Odonthobuthus doriae. , 2008, Toxicon : official journal of the International Society on Toxinology.

[81]  Diane Nelson Bryen,et al.  Web accessibility design recommendations for people with cognitive disabilities , 2008 .

[82]  Z. Cao,et al.  Molecular cloning and electrophysiological studies on the first K+ channel toxin (LmKTx8) derived from scorpion Lychas mucronatus , 2007, Peptides.

[83]  P. Calabresi,et al.  Characterization of the Functional Properties of the Voltage-Gated Potassium Channel Kv1.3 in Human CD4+ T Lymphocytes1 , 2007, The Journal of Immunology.

[84]  Z. Cao,et al.  Cloning and characterization of BmK86, a novel K+ -channel blocker from scorpion venom. , 2007, Biochemical and biophysical research communications.

[85]  S. Feske.  Calcium signalling in lymphocyte activation and disease , 2007, Nature Reviews Immunology.

[86]  N. Zilberberg,et al.  Isolation of the first toxin from the scorpion Buthus occitanus israelis showing preference for Shaker potassium channels , 2007, FEBS letters.

[87]  R. C. Rodríguez de la Vega,et al.  Transcriptome analysis of the venom gland of the Mexican scorpion Hadrurus gertschi (Arachnida: Scorpiones) , 2007, BMC Genomics.

[88]  S. Griffey,et al.  Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases , 2006, Proceedings of the National Academy of Sciences.

[89]  J. Tytgat,et al.  A novel toxin from the venom of the scorpion Tityus trivittatus, is the first member of a new α‐KTX subfamily , 2006, FEBS letters.

[90]  Christine Beeton,et al.  Potassium Channels, Memory T Cells, and Multiple Sclerosis , 2005, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[91]  B. Rudy,et al.  International Union of Pharmacology. LIII. Nomenclature and Molecular Relationships of Voltage-Gated Potassium Channels , 2005, Pharmacological Reviews.

[92]  Juan A. Fernández,et al.  Novel alpha-KTx peptides from the venom of the scorpion Centruroides elegans selectively blockade Kv1.3 over IKCa1 K+ channels of T cells. , 2005, Toxicon : official journal of the International Society on Toxinology.

[93]  S. Feske,et al.  A severe defect in CRAC Ca2+ channel activation and altered K+ channel gating in T cells from immunodeficient patients , 2005, The Journal of experimental medicine.

[94]  So Yeong Lee,et al.  Molecular diversity and function of voltage-gated (Kv) potassium channels in epithelial cells. , 2005, The international journal of biochemistry & cell biology.

[95]  Michael P. Ferber,et al.  Conkunitzin-S1 Is the First Member of a New Kunitz-type Neurotoxin Family , 2005, Journal of Biological Chemistry.

[96]  Jan Tytgat,et al.  An unusual fold for potassium channel blockers: NMR structure of three toxins from the scorpion Opisthacanthus madagascariensis. , 2005, The Biochemical journal.

[97]  L. Possani,et al.  Anuroctoxin, a New Scorpion Toxin of the α-KTx 6 Subfamily, Is Highly Selective for Kv1.3 over IKCa1 Ion Channels of Human T Lymphocytes , 2005, Molecular Pharmacology.

[98]  P. Calabresi,et al.  Targeting Effector Memory T Cells with a Selective Peptide Inhibitor of Kv1.3 Channels for Therapy of Autoimmune Diseases , 2005, Molecular Pharmacology.

[99]  M. Vitolo,et al.  Restrained eating behavior and obesity , 2005 .

[100]  M. De Waard,et al.  Evidence for Domain-specific Recognition of SK and Kv Channels by MTX and HsTx1 Scorpion Toxins* , 2004, Journal of Biological Chemistry.

[101]  R. Norton,et al.  Potassium channel blockade by the sea anemone toxin ShK for the treatment of multiple sclerosis and other autoimmune diseases. , 2004, Current medicinal chemistry.

[102]  R. C. Rodríguez de la Vega,et al.  Current views on scorpion toxins specific for K+-channels. , 2004, Toxicon : official journal of the International Society on Toxinology.

[103]  M. Ayeb,et al.  Kbot1, a three disulfide bridges toxin from Buthus occitanus tunetanus venom highly active on both SK and Kv channels , 2004, Peptides.

[104]  L. Kaczmarek,et al.  Kv1.3 Channel Gene-Targeted Deletion Produces “Super-Smeller Mice” with Altered Glomeruli, Interacting Scaffolding Proteins, and Biophysics , 2004, Neuron.

[105]  T. Kawai,et al.  Selective Blockade of Voltage‐Gated Potassium Channels Reduces Inflammatory Bone Resorption in Experimental Periodontal Disease , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[106]  L. Kaczmarek,et al.  Compensatory Anion Currents in Kv1.3 Channel-deficient Thymocytes* , 2003, Journal of Biological Chemistry.

[107]  P. Calabresi,et al.  The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS. , 2003, The Journal of clinical investigation.

[108]  M. Landau,et al.  Transfer of alopecia areata in the human scalp graft/Prkdc(scid) (SCID) mouse system is characterized by a TH1 response. , 2003, Clinical immunology.

[109]  L. Kaczmarek,et al.  The voltage-gated potassium channel Kv1.3 regulates energy homeostasis and body weight. , 2003, Human molecular genetics.

[110]  P. Mansuelle,et al.  Covalent structure and some pharmacological features of native and cleaved α‐KTx12−1, a four disulfide‐bridged toxin from Tityus serrulatus venom , 2003, Journal of peptide science : an official publication of the European Peptide Society.

[111]  L. Possani,et al.  Disulfide bridges and blockage of Shaker B K(+)-channels by another butantoxin peptide purified from the Argentinean scorpion Tityus trivittatus. , 2003, Toxicon : official journal of the International Society on Toxinology.

[112]  R. C. Rodríguez de la Vega,et al.  Two novel toxins from the Amazonian scorpion Tityus cambridgei that block Kv1.3 and Shaker B K(+)-channels with distinctly different affinities. , 2002, Biochimica et biophysica acta.

[113]  S. Dhanasekaran,et al.  The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.

[114]  Shoba Ranganathan,et al.  kappa-Hefutoxin1, a novel toxin from the scorpion Heterometrus fulvipes with unique structure and function. Importance of the functional diad in potassium channel selectivity. , 2002, The Journal of biological chemistry.

[115]  A. Wickenden.  K(+) channels as therapeutic drug targets. , 2002, Pharmacology & therapeutics.

[116]  I. Huys,et al.  Purification, characterization and biosynthesis of parabutoxin 3, a component of Parabuthus transvaalicus venom. , 2002, European journal of biochemistry.

[117]  S. Choe,et al.  Ion channel structure: Potassium channel structures , 2002, Nature Reviews Neuroscience.

[118]  K. Chandy,et al.  Selective blockade of T lymphocyte K+ channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[119]  E. Christophers.  Psoriasis − epidemiology and clinical spectrum , 2001, Clinical and experimental dermatology.

[120]  Mark J. Miller,et al.  Up-regulation of the IKCa1 Potassium Channel during T-cell Activation , 2000, The Journal of Biological Chemistry.

[121]  R. Khanna,et al.  Suppression of the rat microglia Kv1.3 current by src‐family tyrosine kinases and oxygen/glucose deprivation , 2000, The European journal of neuroscience.

[122]  L. Schlichter,et al.  A Kv1.5 to Kv1.3 Switch in Endogenous Hippocampal Microglia and a Role in Proliferation , 1999, The Journal of Neuroscience.

[123]  A. Gilhar,et al.  Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice. , 1999, The journal of investigative dermatology. Symposium proceedings.

[124]  G A Gutman,et al.  A unified nomenclature for short-chain peptides isolated from scorpion venoms: alpha-KTx molecular subfamilies. , 1999, Trends in pharmacological sciences.

[125]  Keli Xu,et al.  Calcium oscillations increase the efficiency and specificity of gene expression , 1998, Nature.

[126]  C. June,et al.  Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells. , 1998 .

[127]  A. Koschak,et al.  Subunit Composition of Brain Voltage-gated Potassium Channels Determined by Hongotoxin-1, a Novel Peptide Derived fromCentruroides limbatus Venom* , 1998, The Journal of Biological Chemistry.

[128]  M. Péter,et al.  Pandinus imperator scorpion venom blocks voltage-gated K+ channels in human lymphocytes. , 1998, Biochemical and biophysical research communications.

[129]  O. Pongs,et al.  Purification, characterization, and synthesis of three novel toxins from the Chinese scorpion Buthus martensi, which act on K+ channels. , 1997, Biochemistry.

[130]  Judy H. Cho,et al.  Confirmation of a Susceptibility Locus for Crohn's Disease on Chromosome 16 , 1997, Inflammatory bowel diseases.

[131]  N. Sigal,et al.  Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. , 1997, Journal of immunology.

[132]  K. Chandy,et al.  The Signature Sequence of Voltage-gated Potassium Channels Projects into the External Vestibule* , 1996, The Journal of Biological Chemistry.

[133]  G. Crabtree,et al.  Rapid shuttling of NF-AT in discrimination of Ca2+ signals and immunosuppression , 1996, Nature.

[134]  James E. Hall,et al.  Topology of the pore-region of a K+ channel revealed by the NMR-derived structures of scorpion toxins , 1995, Neuron.

[135]  A. Fischer,et al.  A primary T-cell immunodeficiency associated with defective transmembrane calcium influx. , 1995, Blood.

[136]  S. Marom,et al.  State-dependent inactivation of the Kv3 potassium channel. , 1994, Biophysical journal.

[137]  R. MacKinnon,et al.  Purification and characterization of three inhibitors of voltage-dependent K+ channels from Leiurus quinquestriatus var. hebraeus venom. , 1994, Biochemistry.

[138]  G A Gutman,et al.  Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. , 1994, Molecular pharmacology.

[139]  M. Garcia-Calvo,et al.  Purification, characterization, and biosynthesis of margatoxin, a component of Centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels. , 1993, The Journal of biological chemistry.

[140]  R. Lewis,et al.  Mitogen-regulated Ca2+ current of T lymphocytes is activated by depletion of intracellular Ca2+ stores. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[141]  J. Maassen,et al.  Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness , 1992, Nature Genetics.

[142]  H. Rochat,et al.  Kaliotoxin, a novel peptidyl inhibitor of neuronal BK-type Ca(2+)-activated K+ channels characterized from Androctonus mauretanicus mauretanicus venom. , 1992, The Journal of biological chemistry.

[143]  J. Lie.  Diagnostic histopathology of major systemic and pulmonary vasculitic syndromes. , 1990, Rheumatic diseases clinics of North America.

[144]  M. Navia,et al.  Purification, sequence, and model structure of charybdotoxin, a potent selective inhibitor of calcium-activated potassium channels. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[145]  L. Bradley,et al.  Rheumatoid arthritis: review of psychological factors related to etiology, effects, and treatment. , 1985, Psychological bulletin.

[146]  C. Deutsch,et al.  K channels in T lymphocytes: a patch clamp study using monoclonal antibody adhesion , 1984, Nature.

[147]  S. Malek,et al.  Chronic Lymphocytic Leukemia , 2019, Methods in Molecular Biology.

[148]  D. Hafler,et al.  Amendment history : Corrigendum ( June 2002 ) GAD 65-reactive T cells are activated in patients with autoimmune type 1 a diabetes , 2018 .

[149]  M. Frieri,et al.  Systemic lupus erythematosus and atherosclerosis: Review of the literature. , 2016, Autoimmunity reviews.

[150]  M. Kirpichnikov,et al.  Vietnamese Heterometrus laoticus scorpion venom: evidence for analgesic and anti-inflammatory activity and isolation of new polypeptide toxin acting on Kv1.3 potassium channel. , 2014, Toxicon : official journal of the International Society on Toxinology.

[151]  S. Nathan,et al.  Animal Venoms in Medicine , 2014 .

[152]  E. Arantes,et al.  Scorpion Venom Research Around the World: Tityus serrulatus , 2014 .

[153]  P. Pedarzani,et al.  The Olfactory Bulb: A Metabolic Sensor of Brain Insulin and Glucose Concentrations via a Voltage-Gated Potassium Channel. , 2010, Results and problems in cell differentiation.

[154]  H. Rochat,et al.  Animal toxins: state of the art - perspectives in health and biotechnology , 2009 .

[155]  S. Grissmer,et al.  K+ channel types targeted by synthetic OSK1, a toxin from Orthochirus scrobiculosus scorpion venom. , 2005, The Biochemical journal.

[156]  G. Lippens,et al.  Cobatoxin 1 from Centruroides noxius scorpion venom: chemical synthesis, three-dimensional structure in solution, pharmacology and docking on K+ channels. , 2004, The Biochemical journal.

[157]  G. Gutman,et al.  Structural and Biochemical Features of the Kv1.3 Potassium Channel: An Aid to Guided Drug Design , 1997 .

[158]  S. Grabbe,et al.  Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. , 1996, American journal of contact dermatitis : official journal of the American Contact Dermatitis Society.

[159]  M. Cahalan,et al.  Potassium and calcium channels in lymphocytes. , 1995, Annual review of immunology.

[160]  K. Chandy,et al.  A voltage‐gated potassium channel in human T lymphocytes. , 1985, The Journal of physiology.